Contraceptive prevalence, any modern method in Serbia
Serbia: Contraceptive prevalence, any modern method was 21.7% in 2019. ▲ Rising
Contraceptive prevalence, any modern method in Serbia, 1970–2019
Source: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of all women ages 15-49.
Analysis
Serbia recorded 21.7% for contraceptive prevalence, any modern method in 2019.
Compared with earlier readings it is down 28.3% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Serbia peaked at 30.3% in 2010 and was at its lowest, 3.7%, in 1970.
Serbia ranks 49th of 62 countries on this measure, in the bottom quarter.
Contraceptive prevalence, any modern method in Serbia, year by year
| Year | % of all women ages 15-49 | Change |
|---|---|---|
| 1970 | 3.7% | — |
| 2006 | 22.4% | +506.6% |
| 2010 | 30.3% | +35.1% |
| 2014 | 22.2% | -26.7% |
| 2019 | 21.7% | -2.1% |
Serbia compared with similar countries
- Serbia's 21.7% is below the median for upper middle income countries, which is 41.6%, 52% of the median. (20 countries reporting)
- Serbia's 21.7% is below the median for Europe & Central Asia, which is 43.6%, 50% of the median. (9 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1970s | 3.7% | 3.7% | 3.7% | 1 |
| 2000s | 22.4% | 22.4% | 22.4% | 1 |
| 2010s | 24.8% | 21.7% | 30.3% | 3 |
Countries ranked near Serbia
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,502 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.67 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.022 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.67 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Serbia?
- Contraceptive prevalence, any modern method in Serbia was 21.7% in 2019, according to Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Serbia?
- The highest recorded value was 30.3% in 2010.
- What is the lowest contraceptive prevalence, any modern method recorded in Serbia?
- The lowest recorded value was 3.7% in 1970.
- How does Serbia rank for contraceptive prevalence, any modern method?
- Serbia ranks 49th out of 62 countries with data for 2019.
- Is contraceptive prevalence, any modern method rising or falling in Serbia?
- Over the last ten years it is down 28.3%. The long-run trend across the full record is rising.
- Where does this Serbia data come from?
- The figures come from Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of all women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of all women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.